Spatial and epidemiological profile of COVID-19 in the Brazilian North region between the years

Authors

DOI:

https://doi.org/10.33448/rsd-v13i1.44726

Keywords:

Northern region of Brazil; COVID-19; Pandemic; Epidemiological and spatial profile.

Abstract

Objective: To analyze data on COVID-19 in the Northern region of Brazil from 2020 to 2022. Methods: A retrospective cross-sectional analytical-descriptive study was conducted, using digital epidemiological and documentary data collected between 2020 and 2022. Results: The analysis of the distribution and occupancy of hospital beds, the availability and distribution of ventilators, and the distribution of medications used for COVID-19 treatment allowed the evaluation of the effectiveness of health policies implemented by state and municipal governments during the pandemic in the Northern region of Brazil. The study showed a trend of decreasing hospital bed occupancy, possibly due to increased availability, prevention measures, and mass vaccination of the population. However, it highlighted the need for a quality healthcare system with adequate resources and trained healthcare professionals to improve the response to the pandemic. Conclusion: The integrated analysis of the data on COVID-19 in the Northern region of Brazil provided a comprehensive overview of the pandemic and identified potential shortcomings in the response to it. This study highlights the need for effective and equitable health policies, resources allocation, and the adaptation of treatment strategies based on the evolution of scientific knowledge of COVID-19 and its variants.

References

Almeida, J. B., et al. (2020). Oxygen shortage crisis in Manaus during the COVID-19 pandemic: Perspectives from healthcare workers. Journal of Health Management, 18(2), 157-172.

Axfors, C., Schmitt, A. M., & Janiaud, P. (2021). Chloroquine for COVID-19: What do we know? Clinical Microbiology and Infection, 27(1), 9-12.

Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020). Severe COVID-19. New England Journal of Medicine, 383(25), 2451-2460.

Brasil, Ministério da Saúde. (2020). Protocolo de Manejo Clínico da COVID-19 1a edição revisada. Retrieved from https://bvsms.saude.gov.br/bvs/publicacoes/manejo_clinico_COVID-19 _atencao_especializada.pdf

Brasil, Ministério da Saúde. (2021, Apr 8). O Que É a COVID-19? Retrieved from https://www.gov.br/saude/pt-br/coronavirus/o-que-e-o-coronavirus

Chag, K., et al. (2021). COVID-19 vaccination: Impact on hospitalizations and mortality. medRxiv.

Chinazzi, M., Davis, J. T., Ajelli, M., Gioannini, C., Litvinova, M., Merler, S., & Viboud, C. (2020). The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science, 368(6489), 395-400.

Clark, A., et al. (2020). Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study. The Lancet Global Health, 8(8), e1003-e1017.

Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., & Uriel, N. (2020). COVID-19 and cardiovascular disease. Circulation, 141(20), 1648-1655.

Domingues, C. M. A. S. (2023). Desafios para a realização da campanha de vacinação contra a COVID-19 no Brasil. Cadernos de Saúde Pública, 37.

Ferguson, N. M., Laydon, D., Nedjati-Gilani, G., Imai, N., Ainslie, K., Baguelin, M., & Dighe, A. (2020). Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team.

Fio Cruz. (2022). Processo saúde-doença [Internet]. Determinantes Sociais da Saúde. Retrieved from https://dssbr.ensp.fiocruz.br/glossary/processo-saude-doenca/

Fontanet, A., et al. (2021). SARS-CoV-2 variants and ending the COVID-19 pandemic. The Lancet Infectious Diseases, 21(6), e195-e196.

Freitas, A. R. R., Napimoga, M., & Donalisio, M. R. (2020). Assessing the severity of COVID-19. Epidemiologia e Serviços de Saúde, 29(2).

Fleury, S., & Fava, V. M. D. (2022). Vacina contra COVID-19: arena da disputa federativa brasileira. Saúde em Debate, 46, 248-264.

Gatto, M., Bertuzzo, E., Mari, L., Miccoli, S., Carraro, L., Casagrandi, R., & Rinaldo, A. (2020). Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures. Proceedings of the National Academy of Sciences, 117(19), 10484-10491.

Gonçalves, C. W. B., et al. (2020). Incidence of COVID-19 in the states of the northern region of Brazil. Revista de Prevenção da Infecção e Saúde, 6.

Grasselli, G., et al. (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA, 323(16), 1574-1581.

Guan, W.J., et al. (2020). Comorbidity and its impact on 1590 patients with COVID-19 in China: A Nationwide Analysis. European Respiratory Journal, 55(5), 2000547.

Hallal, P. C., Hartwig, F. P., Horta, B. L., Silveira, M. F., Struchiner, C. J., Vidaletti, L. P., & Barros, F. C. (2020). SARS-CoV-2 antibody prevalence in Brazil: Results from two successive nationwide serological household surveys. The Lancet Global Health, 8(11), e1390-e1398.

Harrison, S. L., Fazio-Eynullayeva, E., Lane, D. A., Underhill, P., & Lip, G. Y. H. (2020). Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis. PLoS Medicine, 17(9), e1003321.

Harvey, W. T., Carabelli, A. M., Jackson, B., Gupta, R. K., Thomson, E. C., Harrison, E. M., & Consortium, C.-G. U. (2021). SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology, 19(7), 409-424.

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506.

IBGE. (2021). Regiões de planejamento e regiões metropolitanas. Instituto Brasileiro de Geografia e Estatística. Recuperado em 21 de abril de 2023, de https://www.ibge.gov.br/geociencias-novoportal/cartas-e-mapas/redes-geograficas/15778-regioes-de-planejamento-e-regioes-metropolitanas.html?=&t=o-que-e.

Jin, J. M., et al. (2020). Gender differences in patients with COVID-19: Focus on severity and mortality. Frontiers in Public Health, 8, 152.

Kandel, N., Chungong, S., Omaar, A., & Xing, J. (2020). Health security capacities in the context of COVID-19 outbreak: An analysis of International Health Regulations annual report data from 182 countries. The Lancet, 395(10229), 1047-1053.

Kraemer, M. U., et al. (2020). The effect of human mobility and control measures on the COVID-19 epidemic in China. Science, 368(6490), 493-497.

Lima, M. S. (2021). The oxygen crisis in Manaus: Lessons learned and the need for preparedness. Revista Brasileira de Terapia Intensiva, 33(3), 365-371.

MacDonald, N. E., et al. (2021). COVID-19 and vaccination: A review of the ongoing development and the role of public health in promoting vaccination. Vaccine, 39(6), 900-911.

Majumder, M. S., & Mandl, K. D. (2020). Early in the epidemic: Impact of preprints on global discourse about COVID-19 transmissibility. The Lancet Global Health, 8(5), e627-e630.

Malta, D. C., Szwarcwald, C. L., Barros, M. B. D. A., Gomes, C. S., Machado, Í. E., Souza Júnior, P. R. B. D., & Gracie, R. (2020). A pandemia da COVID-19 e as mudanças no estilo de vida dos brasileiros adultos: um estudo transversal, 2020. Epidemiologia e Serviços de Saúde, 29(4), e2020407.

O'Driscoll, M., et al. (2021). Age-specific mortality and immunity patterns of SARS-CoV-2. Nature, 590(7844), 140-145.

Oliveira, F. A. (2022). Assessing the effectiveness of vaccination strategies in controlling COVID-19: A case study of Manaus, Belém, and Santarém. Journal of Public Health Management and Practice, 28(1), 45-57.

Peckham, H., et al. (2020). Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications, 11(1), 1-10.

Peeling, R. W., Wedderburn, C. J., Garcia, P. J., Boeras, D., Fongwen, N., Nkengasong, J., ... & Mabey, D. (2020). Serology testing in the COVID-19 pandemic response. The Lancet Infectious Diseases, 20(9), e245-e249.

Rocha, P. L., & Pereira, V. S. (2022). Analysis of medication expenditures and its correlation with COVID-19 case fatality rate: A case study of Manaus. Health Economics and Outcomes Research, 12(3), 245-259.

Santos, J. C., & Costa, M. F. (2022). Impact of oxygen supply shortage on COVID-19 patient outcomes in Manaus. Journal of Clinical Medicine Research, 14(2), 87-96.

Santos, R. M., et al. (2021). Impact of vaccination on COVID-19 cases and deaths in Manaus, Belém, and Santarém: A retrospective analysis. Brazilian Journal of Infectious Diseases, 15(4), 312-328.

Silva, A. B., & Souza, C. D. (2020). Vaccine effectiveness and COVID-19 recovery in Manaus, Belém, and Santarém: A comparative study. Journal of Epidemiology and Public Health, 8(2), 120-135.

Silva Filho, P. S., de Sousa Silva, M. J., Júnior, E. J. F., Rocha, M. M. L., Araujo, I. A., de Carvalho, I. C. S., & Mesquita, G. V. (2023). Vacinas contra Coronavírus (COVID-19; SARS-COV-2) no Brasil: um panorama geral. Research, society and development, 10(8), e26310817189-e26310817189.

Ventola, C. L. (2015). The antibiotic resistance crisis: Part 1: Causes and threats. Pharmacy and Therapeutics, 40(4), 277-283.

WHO. (2020). "Solidarity" clinical trial for COVID-19 treatments. World Health Organization. https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON-18june2020-who

WHO. (2021). Clinical management of COVID-19: Interim guidance, 25 January 2021. World Health Organization. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1

Wilder-Smith, A., Freedman, D. O., & Vannice, K. (2020). Challenges in public health responses to COVID-19 in rural America. The Lancet Infectious Diseases, 20(10), 1103-1104.

Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., & Schultze, A. (2020). Factors associated with COVID-19 -related death using OpenSAFELY. Nature, 584(7821), 430-436.

Wirtz, V. J., Hogerzeil, H. V., Gray, A. L., Bigdeli, M., de Joncheere, C. P., Ewen, M. A., & Laing, R. O. (2017). Essential medicines for universal health coverage. The Lancet, 389(10067), 403-476.

Wu, C., et al. (2020). Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 934-943.

Zhou, F., et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054-1062.

Published

10/01/2024

How to Cite

BARBOSA, E. M. .; RUSSILLO, E. da R. .; SILVA, E. S. C. da .; ANDRADE, H. C. Q. .; GUIMARÂES, H. S. .; PEIXOTO, I. C. de S. .; BRABO, R. C. .; RODRIGUES, T. de A. .; ROSENDO, T. de O. .; RODRIGUES, M. H. C. . Spatial and epidemiological profile of COVID-19 in the Brazilian North region between the years . Research, Society and Development, [S. l.], v. 13, n. 1, p. e4313144726, 2024. DOI: 10.33448/rsd-v13i1.44726. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/44726. Acesso em: 23 jun. 2024.

Issue

Section

Health Sciences